Cloudbyz

Executive Summary

Cloudbyz is a U.S.-based digital health company founded in 2014, headquartered in San Jose, California. The company offers a unified eClinical trial management platform that integrates Clinical Trial Management System (CTMS) and Safety & Pharmacovigilance (PV) modules. Its solution aims to streamline clinical trial operations, enhance collaboration among stakeholders, and ensure regulatory compliance, ultimately accelerating trial timelines and improving outcomes. Cloudbyz targets biopharma sponsors, CROs, and research sites seeking to replace fragmented legacy systems with a single, integrated platform. As a private company with no disclosed funding or valuation, Cloudbyz operates in a competitive market dominated by larger players like Veeva and Medidata. However, its focus on a unified, end-to-end solution for both CTMS and safety distinguishes it from point solutions. The company is likely seeking to scale its customer base and potentially raise capital to fuel growth and product development. Key upcoming catalysts include the launch of an AI-powered analytics module to derive insights from trial data, a strategic partnership with a major CRO to expand market reach, and a potential Series A or B funding round to accelerate commercialization. These events could significantly enhance Cloudbyz's market position and adoption.

Upcoming Catalysts (preview)

• Q3 2026Launch of AI-Powered Analytics Module70% success
• Q4 2026Strategic Partnership with a Top-20 CRO50% success
• TBDSeries A or B Funding Round60% success